Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma

Detalhes bibliográficos
Autor(a) principal: Longatto Filho, Adhemar
Data de Publicação: 2009
Outros Autores: Pinheiro, Céline, Martinho, Olga Catarina Lopes, Moreira, Marise A. R., Ribeiro, Luiz F. J., Queiroz, Geraldo Silva, Schmit, Fernando C., Baltazar, Fátima, Reis, R. M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/29708
Resumo: Art. No. 212
id RCAP_ba300c9780898d00746f43a2fbecdfaa
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/29708
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinomaScience & TechnologyArt. No. 212BACKGROUND: Adenosquamous carcinoma of the uterine cervix is an infrequent but aggressive subtype of cervical cancer. A better understanding of its biological behaviour is warranted to define more accurate prognosis and therapeutic targets. Currently, the blockage of receptor tyrosine kinase (RTKs) activity is an efficient therapeutic strategy for many different cancers. The objective of this study was to investigate EGFR, PDGFRA and VEGFR2 RTKs overexpression and activating gene mutations in a cohort of 30 adenosquamous carcinomas of the uterine cervix. METHODS: EGFR, PDGFRA and VEGFR2 immunohistochemistry was performed in all samples, followed by DNA isolation from the gross macroscopically dissection of the neoplastic area. Screening for EGFR (exons 18-21) and PDGFRA (exons 12, 14 and 18) mutations was done by PCR--single-strand conformational polymorphism (PCR-SSCP). RESULTS: Despite the presence of EGFR immunohistochemical positive reactions in 43% (13/30) of the samples, no EGFR activating mutations in the hotspot region (exons 18-21) were identified. A silent base substitution (CAG>CAA) in EGFR exon 20 at codon 787 (Q787Q) was found in 17 cases (56%). All PDGFRA immunohistochemical reactions were positive and consistently observed in the stromal component, staining fibroblasts and endothelial cells, as well as in the cytoplasm of malignant cells. No activating PDGFRA mutations were found, yet, several silent mutations were observed, such as a base substitution in exon 12 (CCA>CCG) at codon 567 (P567P) in 9 cases and in exon 18 (GTC>GTT) at codon 824 (V824V) in 4 cases. We also observed the presence of base substitutions in intron 14 (IVS14+3G>A and IVS14+49G>A) in two different cases, and in intron 18 (IVS18-50insA) in 4 cases. VEGFR2 positivity was observed in 22 of 30 cases (73.3%), and was significantly associated with lack of metastasis (p=0.038). CONCLUSION: This is the most extensive analysis of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinomas. Despite the absence of EGFR and PDGFRA activating mutations, the presence of overexpression of these three important therapeutic targets in a subset of cases may be important in predicting the sensitivity of adenosquamous carcinoma to specific anti-RTKs drugs.CP and OM are recipients of PhD fellowships from the Portuguese Science and Technology Foundation (FCT) (SFRH/BD/27465/2006 and SFRH/BD/36463/2007, respectively).BioMed Central (BMC)Universidade do MinhoLongatto Filho, AdhemarPinheiro, CélineMartinho, Olga Catarina LopesMoreira, Marise A. R.Ribeiro, Luiz F. J.Queiroz, Geraldo SilvaSchmit, Fernando C.Baltazar, FátimaReis, R. M.20092009-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/29708eng1471-240710.1186/1471-2407-9-21219563658http://www.biomedcentral.com/content/pdf/1471-2407-9-212.pdfinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:28:21Zoai:repositorium.sdum.uminho.pt:1822/29708Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:23:08.252579Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
title Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
spellingShingle Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
Longatto Filho, Adhemar
Science & Technology
title_short Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
title_full Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
title_fullStr Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
title_full_unstemmed Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
title_sort Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
author Longatto Filho, Adhemar
author_facet Longatto Filho, Adhemar
Pinheiro, Céline
Martinho, Olga Catarina Lopes
Moreira, Marise A. R.
Ribeiro, Luiz F. J.
Queiroz, Geraldo Silva
Schmit, Fernando C.
Baltazar, Fátima
Reis, R. M.
author_role author
author2 Pinheiro, Céline
Martinho, Olga Catarina Lopes
Moreira, Marise A. R.
Ribeiro, Luiz F. J.
Queiroz, Geraldo Silva
Schmit, Fernando C.
Baltazar, Fátima
Reis, R. M.
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Longatto Filho, Adhemar
Pinheiro, Céline
Martinho, Olga Catarina Lopes
Moreira, Marise A. R.
Ribeiro, Luiz F. J.
Queiroz, Geraldo Silva
Schmit, Fernando C.
Baltazar, Fátima
Reis, R. M.
dc.subject.por.fl_str_mv Science & Technology
topic Science & Technology
description Art. No. 212
publishDate 2009
dc.date.none.fl_str_mv 2009
2009-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/29708
url http://hdl.handle.net/1822/29708
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1471-2407
10.1186/1471-2407-9-212
19563658
http://www.biomedcentral.com/content/pdf/1471-2407-9-212.pdf
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BioMed Central (BMC)
publisher.none.fl_str_mv BioMed Central (BMC)
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132705512751104